• news.cision.com/
  • aXichem AB/
  • aXichem’s Capsaicin Analogue, aXivite, is Launched in Triquetra Health’s New and Health Promoting Product, GLP-Activate

aXichem’s Capsaicin Analogue, aXivite, is Launched in Triquetra Health’s New and Health Promoting Product, GLP-Activate

Report this content

aXichem AB (publ), (aXichem), a provider of innovative natural analogue ingredients to the nutraceutical market, today announces that a new product, GLP-Activate with aXivite, is launched by the U.S. based company Triquetra Health. The GLP-1 hormone(Glucagon-like peptide 1) is produced in the intestine and is considered to control appetite, cravings, blood sugar and most facets of metabolism. Triquetra Health’s product GLP-Activate can provide the body natural extracts and nutrients that can support the body's own GLP-1 production. The GLP-1 hormone has been identified as one of the keys to healthy weight management and metabolic health.

"GLP-Activate is a new interesting product in for an application where I think aXivite’s unique properties as an ingredient can add significant value. Triquetra Health works in several market areas that fit nicely with aXivite, such as gut health, sports performance, and metabolism. I am very pleased that this collaboration now is established and to be able to contribute to a new generation of products for health and wellness”, says Lucas Altepost, VP and VP of Sales and Marketing at aXichem.

About Triquetra
Triquetra Health is since ten years an established brand in health and wellness. The company collaborates with some of the world’s leading suppliers of ingredients and has always operated with a solid commitment to quality throughout the entire process. Triquetra rigorously test all ingredients and finish products from the farm to the shelf and employ the highest clean manufacturing practices and processes in producing every bottle. More about Triquetra

About phenylcapsaicin and aXivite
aXichem's proprietary molecule, phenylcapsaicin, combines the naturally occurring phenyl group with capsaicin, connected by a triple bond. The result is an innovative natural analog capsaicin with high purity, which in several studies has been shown to have the same health-promoting properties, as well as some unique benefits, as natural capsaicin. Phenylcapsaicin is approved under Novel Food in the EU and GRAS Food in the USA and is marketed for dietary supplements and functional foods under the brand name aXivite.

The information was submitted, through the care of the contact person below, for publication on
15 January 2024, at 08:45 AM CET.

Torsten Helsing, CEO, aXichem, Ph+46 70 686 33 55. Email: torsten.helsing@axichem.se

About aXichem
aXichem develops, patents and markets natural analogue industrial chemicals, i.e., synthetically produced substances that have similar and comparable properties to natural substances. The company's first product is phenylcapsaicin, which the company commercializes under two brands, aXiphen® and aXivite®, as an ingredient in animal feed and dietary supplements, respectively. The business is divided into three market areas with different applications for phenylcapsaicin: as an ingredient in feed for poultry, such as chicken and turkey; as an ingredient in food supplements for gut health, weight control and sports and exercise; and as an ingredient in food supplements for the bio-enhancement of curcumin and melatonin. aXichem is listed on the Nasdaq First North Growth Market. Västra Hamnen Corporate Finance AB is Certified Adviser. More information is available at
www.axichem.com.